Aflac Cancer and Blood Disorders Center, Emory UniversityAtlanta, Georgia, United States
Disclosure information not submitted.
Paper 11 - MIR-449A/340 REWIRE METABOLIC COMMITMENT OF FUSION-NEGATIVE RHABDOMYOSARCOMA VIA MITOCHONDRIAL PYRUVATE CARRIER INHIBITION
Thursday, November 2, 202311:00 AM – 12:30 PM